bearish

New Horizon Health (6606 HK) - Behind the Trading Suspension and the Outlook

338 Views10 Jul 2024 08:55
​Deloitte's delay in publishing New Horizon Health's financial results raises serious concerns about the company's integrity and future prospects. Investors may need to reconsider their involvement.
What is covered in the Full Insight:
  • Introduction
  • Company Background
  • Audit Concerns and Delays
  • Product Market Challenges
  • Outlook and Future Steps
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
ChinaHealth CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
x